Focus on Primary Care - helping GPs diagnose, manage and treat urticaria
Quick reference guide dedicated to helping Primary Care Practioners diagnose, manage and treat urticaria
Our research tells us that General Practitioners can find it difficult to maintain a working knowledge of multiple conditions. As the first point of contact for many conditions it’s important that GPs can access quick reference materials at their fingertips. That’s why we’ve developed this practical guide for primary care practitioners to read up on the definitions of allergy, autoimmunity and urticaria.
Easily printable for quick reference, it includes:
- a handy symptom checker
- visual reference guide for differential diagnosis
- algorithms for diagnosing and treating urticaria in a primary care setting
- second generation treatments
- special populations and important considerations
Related news and insights
Regeneron Pharmaceuticals, Inc., and Sanofi announced a Phase III trial (CUPID STUDY B) evaluating Dupixent (dupilumab) in patients with chronic spontaneous urticaria (CSU) will stop due to futility, based on a pre-specified interim analysis.